flynn	10.3109/10428194.2014.977886	<http://dx.doi.org/10.3109/10428194.2014.977886>; rel="canonical", <http://www.tandfonline.com/doi/pdf/10.3109/10428194.2014.977886>; version="vor"; rel="item"	<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:j.0="http://purl.org/dc/terms/" xmlns:j.1="http://prismstandard.org/namespaces/basic/2.1/" xmlns:owl="http://www.w3.org/2002/07/owl#" xmlns:j.2="http://purl.org/ontology/bibo/" xmlns:j.3="http://xmlns.com/foaf/0.1/"><rdf:Description rdf:about="http://dx.doi.org/10.3109/10428194.2014.977886"><owl:sameAs rdf:resource="info:doi/10.3109/10428194.2014.977886"/><j.0:creator><j.3:Person rdf:about="http://id.crossref.org/contributor/charles-erlichman-ows72jx1h6s9"><j.3:name>Charles Erlichman</j.3:name><j.3:familyName>Erlichman</j.3:familyName><j.3:givenName>Charles</j.3:givenName></j.3:Person></j.0:creator><j.0:isPartOf><j.2:Journal rdf:about="http://id.crossref.org/issn/1042-8194"><j.1:issn>1029-2403</j.1:issn><j.2:issn>1029-2403</j.2:issn><owl:sameAs>urn:issn:1029-2403</owl:sameAs><owl:sameAs>urn:issn:1042-8194</owl:sameAs><j.0:title>Leukemia &amp; Lymphoma</j.0:title><j.1:issn>1042-8194</j.1:issn><j.2:issn>1042-8194</j.2:issn></j.2:Journal></j.0:isPartOf><j.0:publisher>Informa UK Limited</j.0:publisher><j.0:creator><j.3:Person rdf:about="http://id.crossref.org/contributor/betsy-laplant-ows72jx1h6s9"><j.3:name>Betsy LaPlant</j.3:name><j.3:familyName>LaPlant</j.3:familyName><j.3:givenName>Betsy</j.3:givenName></j.3:Person></j.0:creator><j.2:pageEnd>2066</j.2:pageEnd><j.0:date rdf:datatype="http://www.w3.org/2001/XMLSchema#date" >2014-11-19</j.0:date><j.0:title>A phase II study of AZD2171 (cediranib) in the treatment of patients with acute myeloid leukemia or high-risk myelodysplastic syndrome</j.0:title><j.0:creator><j.3:Person rdf:about="http://id.crossref.org/contributor/alcee-jumonville-ows72jx1h6s9"><j.3:name>Alcee Jumonville</j.3:name><j.3:familyName>Jumonville</j.3:familyName><j.3:givenName>Alcee</j.3:givenName></j.3:Person></j.0:creator><j.1:startingPage>2061</j.1:startingPage><j.0:creator><j.3:Person rdf:about="http://id.crossref.org/contributor/patrick-james-flynn-ows72jx1h6s9"><j.3:name>Patrick James Flynn</j.3:name><j.3:familyName>Flynn</j.3:familyName><j.3:givenName>Patrick James</j.3:givenName></j.3:Person></j.0:creator><j.1:volume>56</j.1:volume><j.2:doi>10.3109/10428194.2014.977886</j.2:doi><j.0:creator><j.3:Person rdf:about="http://id.crossref.org/contributor/mark-b-juckett-ows72jx1h6s9"><j.3:name>Mark B. Juckett</j.3:name><j.3:familyName>Juckett</j.3:familyName><j.3:givenName>Mark B.</j.3:givenName></j.3:Person></j.0:creator><j.2:volume>56</j.2:volume><j.0:creator><j.3:Person rdf:about="http://id.crossref.org/contributor/ryan-mattison-ows72jx1h6s9"><j.3:name>Ryan Mattison</j.3:name><j.3:familyName>Mattison</j.3:familyName><j.3:givenName>Ryan</j.3:givenName></j.3:Person></j.0:creator><j.0:identifier>10.3109/10428194.2014.977886</j.0:identifier><owl:sameAs rdf:resource="doi:10.3109/10428194.2014.977886"/><j.0:creator><j.3:Person rdf:about="http://id.crossref.org/contributor/alvaro-moreno-aspitia-ows72jx1h6s9"><j.3:name>Alvaro Moreno-Aspitia</j.3:name><j.3:familyName>Moreno-Aspitia</j.3:familyName><j.3:givenName>Alvaro</j.3:givenName></j.3:Person></j.0:creator><j.1:doi>10.3109/10428194.2014.977886</j.1:doi><j.2:pageStart>2061</j.2:pageStart><j.1:endingPage>2066</j.1:endingPage></rdf:Description></rdf:RDF>
